What Happened?
Shares of credit reporting giant Equifax (NYSE:EFX) jumped 5.6% in the pre-market session after the company reported a 10% increase in third-quarter 2026 revenue to $1.693 billion, fueled by strong growth across its core business segments.
According to a company press release, revenue rose 9% in local currency, propelled by an 8% gain in Diversified Markets and 13% growth in its U.S. Information Solutions (USIS) division. U.S. Mortgage revenue increased 15% despite challenging market conditions. Equifax also highlighted product innovation, noting that its new product Vitality Index—a measure of revenue generated from recent products—exceeded a record 17%. The company returned $158 million to shareholders through share repurchases and a quarterly dividend. This execution demonstrated solid operational momentum, offering investors confidence that growth in diversified data offerings could offset ongoing headwinds in the mortgage sector.
Is now the time to buy Equifax? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Equifax’s shares are somewhat volatile and have had 12 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 18 days ago when the stock gained 2.7% on the news that Barclays lowered its price target on the stock to $155 from $200 while maintaining an Equal Weight rating as part of an earnings preview, citing increasingly negative sentiment in the business services sector.
TipRanks reported that the investment bank reduced its target valuation ahead of the company's upcoming earnings release. The price target revision represents a $45 cut from the previous $200 target. In its assessment, Barclays highlighted growing negative sentiment across the broader business services sector as a key factor influencing the change. Despite the lower target, the brokerage kept its Equal Weight rating on the shares, signaling an expectation that the stock will perform in line with the wider industry.
Equifax is down 18.1% since the beginning of the year, and at $175.31 per share, it is trading 25% below its 52-week high of $233.80 from October 2025. Investors who bought $1,000 worth of Equifax’s shares 5 years ago would now be looking at only $650.01.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.